Lv3
358 积分 2021-04-02 加入
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
24天前
已完结
Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical development
1个月前
已完结
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies
1个月前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
2个月前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
2个月前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
2个月前
已完结
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group
5个月前
已完结
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
10个月前
已完结
846. Pneumocystis Pneumonia in malignancy patients: Who is at risk?
10个月前
已完结
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
10个月前
已完结
皖公网安备34019202002308
